Analysis of resveratrol as a lung cancer chemopreventive agent in A/J mice exposed to benzo[a]pyrene

British Journal of Cancer

Volumn 91, Issue 7, 2004, Pages 1380-1383

  Berge, G ^a   Ovrebo S ^a   Eilertsen, E ^a   Haugen, A ^a   Mollerup, S ^a  

^a NATIONAL INSTITUTE OF OCCUPATIONAL HEALTH   (Norway)

Author keywords

Adducts; Benzo a pyrene; CYP1A1; CYP1B1; Lung carcinogenesis; Resveratrol

Indexed keywords

BENZO[A]PYRENE; CYTOCHROME P450 1A1; CYTOCHROME P450 1B1; POLYCYCLIC AROMATIC HYDROCARBON; RESVERATROL; ANGIOGENESIS INHIBITOR; CYTOCHROME P 450 CYP1B1; CYTOCHROME P-450 CYP1B1; PHENOL DERIVATIVE; STILBENE DERIVATIVE; UNSPECIFIC MONOOXYGENASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRONCHUS MUCOSA; CHEMOPROPHYLAXIS; CONTROLLED STUDY; CYP1A1 GENE; CYP1B1 GENE; DRUG EFFECT; EPITHELIUM CELL; FEMALE; GENE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; LUNG CANCER; LUNG CARCINOGENESIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; ANIMAL; ANIMAL DISEASE; BIOSYNTHESIS; CHEMICALLY INDUCED DISORDER; GENE EXPRESSION REGULATION; GENETICS; LUNG TUMOR;

ANGIOGENESIS INHIBITORS; ANIMALS; ARYL HYDROCARBON HYDROXYLASES; BENZO(A)PYRENE; CHEMOPREVENTION; CYTOCHROME P-450 CYP1A1; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; LUNG NEOPLASMS; MICE; PHENOLS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; STILBENES;

EID: 6944237334     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjc.6602125     Document Type: Article

References (22)

1. Asensi M, Medina I, Ortega A, Carretero J, Bano MC, Obrador E, Estrela JM (2002) Inhibition of cancer growth by resveratrol is related to its low bioavailability. Free Radic Biol Med 33: 387-398
2. Berge G, Mollerup S, Øvrebø S, Hewer A, Phillips DH, Eilertsen E, Haugen A (2004a) Role of estrogen receptor in regulation of polycyclic aromatic hydrocarbon metabolic activation in lung. Lung Cancer 45: 289-297
3. Berge G, Øvrebø S, Botnen IV, Hewer A, Phillips DH, Haugen A, Mollerup S (2004b) Resveratrol inhibits benzo[a]pyrene-DNA adduct formation in human bronchial epithelial cells. Br J Cancer 91: 333-338
4. Ciolino HP, Yeh GC (1999) Inhibition of aryl hydrocarbon-induced cytochrome P-450 1A1 enzyme activity and CYP1A1 expression by resveratrol. Mol Pharmacol 56: 760-767
5. Gescher AJ, Steward WP (2003) Relationship between mechanisms, bioavailability, and preclinical chemopreventive efficacy of resveratrol: a conundrum. Cancer Epidemiol Biomarkers Prev 12: 953-957
6. Hecht SS (2003) Tobacco carcinogens, their biomarkers and tobacco-induced cancer. Nat Rev Cancer 3: 733-744
7. Hecht SS, Isaacs S, Trushin N (1994) Lung tumor induction in A/J mice by the tobacco smoke carcinogens 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and benzo[a]pyrene: a potentially useful model for evaluation of chemopreventive agents. Carcinogenesis 15: 2721-2725
8. Hecht SS, Kenney PM, Wang M, Trushin N, Agarwal S, Rao AV, Upadhyaya P (1999) Evaluation of butylated hydroxyanisole, myo-inositol, curcumin, esculetin, resveratrol and lycopene as inhibitors of benzo[a]pyrene plus 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced lung tumorigenesis in A/J mice. Cancer Lett 137: 123-130
9. Jang M, Cai L, Udeani GO, Slowing KV, Thomas CF, Beecher CW, Fong HH, Farnsworth NR, Kinghorn AD, Mehta RG, Moon RC, Pezzuto JM (1997) Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science 275: 218-220
10. Jemal A, Tiwari RC, Murray T, Ghafoor A, Samuels A, Ward E, Feuer EJ, Thun MJ (2004) Cancer statistics, 2004. CA Cancer J Clin 54: 8-29
11. Kimura Y, Okuda H (2001) Resveratrol isolated from Polygonum cuspidatum root prevents tumor growth and metastasis to lung and tumor-induced neovascularization in Lewis lung carcinoma-bearing mice. J Nutr 131: 1844-1849
12. Mollerup S, Øvrebø S, Haugen A (2001) Lung carcinogenesis: resveratrol modulates the expression of genes involved in the metabolism of PAH in human bronchial epithelial cells. Int J Cancer 92: 18-25
13. Peto R, Lopez AD, Boreham J, Thun M, Heath Jr C, Doll R (1996) Mortality from smoking worldwide. Br Med Bull 52: 12-21
14. Revel A, Raanani H, Younglai E, Xu J, Rogers I, Han R, Savouret JF, Casper RF (2003) Resveratrol, a natural aryl hydrocarbon receptor antagonist, protects lung from DNA damage and apoptosis caused by benzo[a]pyrene. J Appl Toxicol 23: 255-261
15. Sale S, Verschoyle RD, Boocock D, Jones DJ, Wilsher N, Ruparelia KC, Potter GA, Farmer PB, Steward WP, Gescher AJ (2004) Pharmacokinetics in mice and growth-inhibitory properties of the putative cancer chemopreventive agent resveratrol and the synthetic analogue trans 3,4,5,4′- tetramethoxystilbene. Br J Cancer 90: 736-744
16. Scalbert A, Williamson G (2000) Dietary intake and bioavailability of polyphenols. J Nutr 130: 2073S-2085S
17. Schneider Y, Duranton B, Gosse F, Schleiffer R, Seiler N, Raul F (2001) Resveratrol inhibits intestinal tumorigenesis and modulates host-defense-related gene expression in an animal model of human familial adenomatous polyposis. Nutr Cancer 39: 102-107
18. Twombly R (2003) Tobacco use a leading global cancer risk, report says. J Natl Cancer Inst 95: 11-12
19. Vitrac X, Desmouliere A, Brouillaud B, Krisa S, Deffieux G, Barthe N, Rosenbaum J, Merillon JM (2003) Distribution of [14C]-trans-resveratrol, a cancer chemopreventive polyphenol, in mouse tissues after oral administration. Life Sci 72: 2219-2233
20. Workman P, Twentyman P, Balkwill F, Balmain A, Chaplin D, Double J, Embleton J, Newell D, Raymond R, Stables J, Stephens T, Wallace J (1998) United Kingdom co-ordinating committee on cancer research (UKCCCR) guidelines for the welfare of animals in experimental neoplasia (second edition). Br J Cancer 77: 1-10
21. Yu C, Shin YG, Chow A, Li Y, Kosmeder JW, Lee YS, Hirschelman WH, Pezzuto JM, Mehta RG, van Breemen RB (2002) Human, rat, and mouse metabolism of resveratrol. Pharm Res 19: 1907-1914
22. Ziegler CC, Rainwater L, Whelan J, McEntee MF (2004) Dietary resveratrol does not affect intestinal tumorigenesis in Apc(Mird+) mice. J Nutr 134: 5-10